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ABSTRACT
C ytoplasmic dyneins, the principal microtubuleminus-end-directed motor proteins of the cell, areinvolved in many essential cellular processes. The
major form of this enzyme is a complex of at least six protein
subunits, and in mammals all but one of the subunits are
encoded by at least two genes. Here we review current
knowledge concerning the subunits, their interactions, and
their functional roles as derived from biochemical and
genetic analyses. We also carried out extensive database
searches to look for new genes and to clarify anomalies in the
databases. Our analysis documents evolutionary relationships
among the dynein subunits of mammals and other model
organisms, and sheds new light on the role of this diverse
group of proteins, highlighting the existence of two
cytoplasmic dynein complexes with distinct cellular roles.
Introduction
Dyneins are large multi-subunit protein complexes that
undertake a wide range of roles within the cell. They are
adenosine triphosphate (ATP)–driven, microtubule minus-
end-directed molecular motors that can be divided, based on
function, into two classes: axonemal and cytoplasmic dyneins
[1–7] (reviewed in [8,9]). Axonemal dyneins are responsible
for the movement of cilia and ﬂagella. Two cytoplasmic
dynein complexes have been identiﬁed. The most abundant
cytoplasmic dynein complex, cytoplasmic dynein 1, is
involved in functions as diverse as spindle-pole organization
and nuclear migration during mitosis, the positioning and
functioning of the endoplasmic reticulum, the Golgi
apparatus, and the nucleus, and also the minus-end-directed
transport of vesicles, including endosomes and lysosomes,
along microtubules and retrograde axonal transport in
neurons. A second cytoplasmic dynein complex, cytoplasmic
dynein 2, has a role in intraﬂagellar transport (IFT), a process
required for ciliary/ﬂagellar assembly (reviewed in [10]).
The core of the cytoplasmic dynein 1 complex is a
homodimer of two heavy chain polypeptides and associated
intermediate, light intermediate, and light chain polypeptides,
which are deﬁned and named by their molecular mass and
mobility in SDS-PAGE gels (Figure 1A). The protein subunits
are encoded by families of at least two genes, and the
expression patterns of the individual family members are
different in various cell types. At least one of the light chains,
DYNLL1 (LC8), has multiple cellular roles independent of its
participation in a dynein complex. Cytoplasmic dynein 1
interacts with various other proteins including a second
multimer, dynactin, to form the dynein–dynactin complex.
Dynactin is comprised of at least seven different proteins,
which together act as an adaptor that connects the cytoplasmic
dynein motor to a range of cargoes (for review, see [11]).
Interaction with dynactin also increases dynein motor
processivity [12]. Furthermore, dynactin functions
independently of dynein, anchoring microtubules at the
centrosome [13]. Current evidence suggests that the second
cytoplasmic dynein complex, cytoplasmic dynein 2, is also a
homodimer of a distinct heavy chain, DYNC2H1, with
associated light intermediate chain, DYNC2LI1 (Figure 1B). No
other subunits have yet been identiﬁed for this complex, and it
does not appear to interact with the dynactin complex [14–16].
The cytoplasmic dynein proteins are fundamental to the
functioning of all cells, and have recently been shown to be
causally mutated in forms of neurodegeneration [17–19].
They are thus of great interest for mammalian genetic, and
other, studies. We therefore sought to examine the role of
cytoplasmic dynein subunits from a genetic perspective.
During this analysis, we noted considerable confusion in the
human and mouse gene and protein names and mapping
positions. Therefore, we reexamined the mapping locations
for the subunit genes and clariﬁed and updated entries in the
various sequence databases. In doing so, we utilized the
revised consensus nomenclature developed for the
cytoplasmic dynein subunits and their genes (Table 1). We
also deﬁned, as far as possible with current data, homologous
genes in model organisms, including Drosophila, Caenorhabditis
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elegans, Chlamydomonas, and yeast. To further our
understanding of the function of cytoplasmic dynein
subunits, we also brieﬂy examined mutations in this group of
proteins in a variety of model organisms. We do not discuss
dynein-binding proteins such as dynactin, LIS1, or various
kinases, which while important for dynein function, have not
yet been shown to be stoichiometric components of the
cytoplasmic dynein complex.
Human and mouse cytoplasmic dynein subunit genes. The
subunits of the cytoplasmic dynein complexes are resolved
into subunit polypeptides of ;530 kDa (heavy chains), ;74
kDa (intermediate chains), ;33–59 kDa (light intermediate
chains), and ;10–14 kDa (light chains) in SDS-PAGE gels
(Figure 1A). Research on the cytoplasmic dynein subunits has
been undertaken in a wide range of organisms from yeast to
humans. The nomenclature of the mammalian genes
encoding these proteins has drawn on homologs in other
organisms and, consequently, a number of aliases have been
found for any given human or mouse cytoplasmic dynein
subunit. Much of the early research into dynein genetics was
conducted in the biﬂagellate green alga Chlamydomonas on the
dyneins found in the ﬂagellar axoneme, and therefore some
cytoplasmic dynein nomenclature derives from these studies.
For example, mammalian members of the cytoplasmic light
chain families DYNLRB and DYNLL have commonly been
referred to as LC7 and LC8, respectively, which are the names
of homologous Chlamydomonas axonemal dynein subunits.
Nomenclature. The revised classiﬁcation system for
mammalian cytoplasmic dynein (Table 1) recognizes the two
distinct dynein complexes, cytoplasmic dynein 1 and
cytoplasmic dynein 2, and the fact that cytoplasmic dynein
light chains are shared with some axonemal dyneins.
Cytoplasmic dynein subunits are also classiﬁed into
polypeptide families according to sequence similarity within
groups of similarly sized proteins; thus there is sequence
similarity within the dynein gene families (and when
cytoplasmic and axonemal members of the same gene
families are compared) but not among them.
This nomenclature has been approved by the Human
Genome Organization Nomenclature Committee [20] and the
International Committee on Standardized Nomenclature for
Mice. In accordance with their policy, the designation of each
unique cytoplasmic dynein subunit starts with DYNC for
dynein, cytoplasmic, followed by the speciﬁc dynein complex
subtype 1 or 2; for example, cytoplasmic dynein 2 is
designated DYNC2. The shared light chains start with DYN.
Each subunit is designated with a letter(s) for the size of the
polypeptides, H for the heavy chain, I for the intermediate
chain, LI for the light intermediate chain, and L for the light
chain. Additional letters (T, RB, and L) are used to distinguish
the three distinct light chain families as described in the text.
Individual members of the gene families are assigned
numbers. Standard human and mouse gene nomenclature is
used: italicized upper case for human gene symbols (for
DOI: 10.1371/journal.pgen.0020001.g001
Figure 1. The Mammalian Cytoplasmic Dynein Complexes
(A) Cytoplasmic dynein. (Left panel) Polypeptides of immunoaffinity-purified rat brain cytoplasmic dynein. Polypeptide mass (in kDa) is indicated on the
right side of the gel, and the consensus family names are indicated on the left. (Right panel) Structural model for the association of the cytoplasmic
dynein complex subunits. The core of the cytoplasmic dynein complex is made of two DYNC1H1 heavy chains which homodimerize via regions in their
N-termini. The motor domains are at the C-termini of the heavy chains, the large globular heads of ;350 kDa that are composed of a ring of seven
densities surrounding a central cavity; six of the densities are AAA domains (numbered 1–6). AAA domain 1 is the site of ATP hydrolysis. The
microtubule-binding domain is a projection found on the opposite side of the ring between AAA domains 4 and 5. C is the C-terminus of the heavy
chain that would form the 7th density. Two DYNC1I intermediate chains (IC74) and DYNC1LI light intermediate chains bind at overlapping regions of
the N-terminus of the heavy chain, overlapping with the heavy chain dimerization domains. Dimers of the three light chain families; DYNLT, the Tctex1
light chains; DYNLRB, the Roadblock light chains; and DYNLL, the LC8 light chains, bind to the intermediate chain dimers.
(B) Cytoplasmic dynein 2 complex, structural model for subunit association. This dynein complex has a unique role in IFT and is sometimes known as IFT
dynein. Structural predictions indicate that the heavy chain, DYNC2H1, is similar to the cytoplasmic and axonemal dyneins. The only known subunit of
this complex is a 33- to 47-kDa polypeptide, DYNC2LI1, which is related to the cytoplasmic dynein light intermediate chains. No intermediate chain or
light chains have yet been identified [16].
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example, DYNC1H1), italicized initial upper case and then
lower-case letters for mouse (Dync1h1), and for proteins of
both species, the same symbols in upper case, upright
(DYNC1H1). In accordance with the International Union of
Pure and Applied Chemistry standards, isoforms of the
intermediate chain gene products are referred to with letters.
This nomenclature system can be expanded to other subunits
as appropriate. We refer to mapping positions using the
preﬁxes Hsa (Homo sapiens) for human and Mmu (Mus
musculus) for mouse, followed by the chromosomal
localization e.g. Hsa2q11, Mmu11.
Table 1 lists the aliases, map position, and protein/DNA-
sequence accession data for each known mouse and human
cytoplasmic dynein gene. The greatest number of aliases was
observed for the cytoplasmic dynein 1 heavy chain 1
(DYNC1H1) for which we identiﬁed 15 different names. Some
alternative cytoplasmic dynein gene names have come from
large-scale gene and transcript identiﬁcation efforts such as
the partial DYNC1H1 clone KIAA0325 and its mouse homolog
‘‘mKIA00325,’’ generated by the Kazusa cDNA project [21]. A
small number of gene names have been derived from the
names of DNA markers and cDNA clones used to identify the
genes, for example, cytoplasmic dynein 2 light intermediate
chain 1, DYNC2LI1, was named DKFZp564A033 after the
cDNA sequence and clone of the same name. The heavy chain
gene DYNC1H1 has also been referred to by the name of a
marker, Hp22, generated from its human cDNA sequence, as
well as the rat-derived marker Rk3–8 and a cDNA clone
named HL-3.
Cytoplasmic Dynein Heavy Chain Gene Family
(DYNC1H1, DYNC2H1)
Figure 2A shows the phylogenetic relationships amongst
the dynein heavy chain protein sequences from various
organisms. The heavy chain sequences fall into two distinct
clades, and the relationships within each clade are generally
consistent with known evolutionary distances between the
organisms shown. We note that our phylogeny ﬁts well with
and extends previous phylogenetic analyses of the heavy
chain proteins [22,23]. This analysis indicates that the partial
human sequence DNAH12, (AAB09729) [23], is unlikely to be
a cytoplasmic dynein.
Cytoplasmic dynein heavy chain 1, DYNC1H1. DYNC1H1,
cytoplasmic dynein 1 heavy chain 1, is the largest cytoplasmic
dynein subunit, having;4,600 residues and amolecular weight
of .530 kDa. First identiﬁed in rat spinal cord and brain and
termed Microtubule Associated Protein 1C (MAP1C) [24],
DYNC1H1 is a distant member of the AAA family of ATPases
and is the cytoplasmic counterpart to axonemal dynein heavy
chains [3,25]. DYNC1H1 associates as a homodimer within the
cytoplasmic dynein complex and effects the contact and
translocation of the dynein complex alongmicrotubules via its
large motor domain [8,26] (Figure 1B).
The C-terminal region of DYNC1H1 is the motor domain
of the dynein complex and is conserved in all cytoplasmic and
axonemal dynein heavy chains. This region is arranged as a
heptameric ring with six AAA domains and a seventh domain,
the identity of which remains a matter of discussion (Figure
1B) [12,25,27,28]. AAA domains are regions of ATP binding
and hydrolysis, and thus they generate the energy required
for translocation [29–31]. While the ﬁrst AAA domain is
essential for motor activity [32], reviewed in [30], the ﬁrst four
AAA domains are potentially capable of binding and
hydrolysing ATP [33–35]. Contact of the heavy chain with a
microtubule is established via an ;15-nm projection that
extends between the fourth and ﬁfth AAA domains [28,36].
The N-terminal region of DYNC1H1 is known as the stem,
and force production, and therefore translocation, is thought
to be achieved through the contact and shift of a 10-nm fold
of the stem closest to the ﬁrst AAA domain [37]. DYNC1H1
dimerization also occurs in the stem, and the intermediate
chains and light intermediate chains bind in this region as
well [38,39]. The three light chains bind to the intermediate
chains [40]. Collectively the ﬁve smaller dynein subunits that
bind to the N-terminus of DYNC1H1 make up the cargo-
binding portion of the dynein complex.
The sequence of full-length mammalian DYNC1H1 was
ﬁrst obtained in rat and mouse [41,42]. Human DYNC1H1 was
identiﬁed by screening an adenocarcinoma library with a
partial human cDNA [23,43]. As yet, the only mutations
reported in mammalian heavy chains have been in the mouse:
the Loa and Cra1 strains have allelic point mutations in
Dync1h1 that cause late-onset motor neuron degeneration in
heterozygotes and neuronal apoptosis in homozygotes [17].
The loss of both copies of Dync1h1 has been shown to be lethal
during early embryonic development, with disorganization of
the Golgi complex, improper distribution of endosomes and
lysosomes, and defects in cell proliferation; no phenotype has
yet been reported for heterozygote knock-out mice [44].
In Drosophila, the dynein heavy chain gene, Dhc64C,
functions in oogenesis [45,46], oocyte differentiation [47],
centrosome attachment during mitosis [48], eye development,
cell development in thorax, abdomen, and wing [45], and
axonal transport [49]. Homozygous mutations induced by the
mutagen ethyl methane sulfonate in Dhc64C are larval/pupal
lethal, whilst heterozygotes have defects in bristle formation,
eye development, and fertility [45]. In C. elegans, dynein heavy
chain (dhc-1) is an essential gene, also known as let-354
(LEThal) [50]. Extensive mutational analysis has been
conducted on dhc-1 to produce a range of variants from
recessive/dominant lethals to temperature-sensitive mutants.
The resultant phenotypes invariably include embryonic
lethality, spindle orientation defects, polar body
abnormalities, and excessive blebbing in the early embryo
[51–54].
In the yeast Saccharomyces cerevisiae, heavy chain function
ensures the alignment and orientation of mitotic spindles.
Mutation of the S. cerevisiae heavy chain gene dyn1, which has
50% similarity (28% identity) to DYNC1H1 over 80% of the
protein’s length, has been shown to disrupt spindle
orientation and reduce the ﬁdelity of nuclear segregation
during mitosis [55,56]. Despite this phenotype, dyn1 mutants
remain viable, although dyn1 and kinesin double mutants are
lethal [57]. This observation suggests some functional
redundancy for dynein by kinesin motors in yeast. No
cytoplasmic dynein 1 heavy chain 1 homolog has
unambiguously been identiﬁed in Chlamydomonas, and neither
have dyneins been found in either the Arabidopsis or rice
genomes [58,59] (reviewed in [60]). There are many dynein
heavy chains in the Chlamydomonas genome. However, with the
exception of DYNC2H1, they appear to be components of the
axonemal dyneins.
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Cytoplasmic dynein 2 heavy chain 1, DYNC2H1. The
cytoplasmic dynein 2 heavy chain, DYNC2H1, was originally
identiﬁed in sea urchin embryos by Gibbons and colleagues
and was termed DYH1b [61]. It is much less abundant than
DYNC1H1 and does not appear to heterodimerize with
DYNC1H1; biochemical analyses suggest that DYNC2H1 is a
homodimer [16]. DYNC2H1 contains regions characteristic of
cytoplasmic dyneins, for example, human DYNC1H1 and
DYNC2H1 sequences are similar within both the motor
region and around the light intermediate chain–binding site
[15]. However, the expression of its mRNA increases during
embryonic reciliation, a property typical of axonemal
dyneins, suggesting a ﬂagellar role for an otherwise
cytoplasmic-like dynein heavy chain. The ﬂagellar properties
of DYNC2H1 were clariﬁed with its identiﬁcation as the
motor responsible for retrograde (tip to base) IFT, in
Chlamydomonas, a process required for assembly and
maintenance of the eukaryotic cilium/ﬂagellum [6,22].
DOI: 10.1371/journal.pgen.0020001.g002
Figure 2. Panel Showing the Protein-Based Phylogenies of the Cytoplasmic Dynein Subunit Families
Species names are shown with NCBI/GenBank gene/protein names. NCBI/GenBank protein-sequence accession numbers are given in Table S1.
Orthologous human, mouse, and rat gene names use the revised systematized consensus nomenclature (e.g. DYNC1H1 in humans, mouse, and rat).
Relationships amongst dynein sequences of different species do not necessarily reflect the evolutionary relationships amongst species; see [208] and
[209] for further details. Named clades are indicated in the right margins. Bayesian and maximum-likelihood bootstrap values are shown as percentages
(top and bottom, respectively), adjacent to branch points. Asterisks denote bootstraps below 50%. Filled circles denote bootstraps at 100%. Scale-bar
represents evolutionary distance (estimated numbers of amino-acid substitutions per site).
(A) Cytoplasmic dynein heavy chain family. Chlamydomonas outer arm heavy chain (ODA11) is used as the outgroup. DNAH12frag is the partial
axonemal heavy chain fragment taken from [23]. For mouse DYNC2H1, XP_35830, only partial protein sequence (336aa) was available in the GenBank
database. Adding this partial sequence to our analysis resulted in spurious clustering, therefore we obtained an extended, putative sequence by using
BLAST (TBLASTN) against the mouse genome (Build 32) with human and rat sequences XP_370652 and NP_075413, respectively. Incomplete mouse
genomic assembly at the DYNC2H1 locus yielded a truncated sequence 3455 amino acids in length, 85% the length of human DYNC2H1.
(B) Cytoplasmic dynein intermediate chain family. The Chlamydomonas IC2 (ODA6) is used as the outgroup.
(C) Cytoplasmic dynein light intermediate chain family. There does not appear to be a sufficiently distant homolog in Chlamydomonas to be used as an
outgroup in this analysis, therefore ODA11 (Q39610, a heavy chain protein) was chosen as the outgroup for this tree.
(D) Cytoplasmic dynein light chain Tctex1 family. The Chlamydomonas LC2 light chain is used as the outgroup.
(E) Cytoplasmic dynein light chain Roadblock family. The Chlamydomonas outer arm dynein LC7a, is used as the outgroup.
(F) Cytoplasmic dynein light chain LC8 family. The Chlamydomonas Q39579 sequence is used as an outgroup. This phylogeny is poorly resolved, with
low bootstrap support values and posterior clade probabilities, most likely due to there being little variation amongst the ingroup sequences. We found
good support for the LC8 light chain 1 clade, and some support for the LC8 light chain 2 clade, of four vertebrate sequences. The relationships of the
two sequences, C. elegans and Takifugu were poorly resolved, and therefore we have not included these in the LC8 light chain 2 clade.
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DYNC2H1 is also important in modiﬁed ciliary structures
such as nematode mechanosensory neurons [62] and
vertebrate photoreceptors [63,64]. In C. elegans, the DYNC2H1
homolog, che-3, is expressed in ciliated sensory neurons
which are thought to be involved in odorant chemotaxis [65].
Mutations of che-3 affect IFT, the establishment and
maintenance of sensory cilia, which are stunted and swollen
in the mutants, [62,66], chemotactic behavior [67], and
formation of the third larval stage, dauer formation [68].
The ﬁrst mammalian DYNC2H1 gene was described in rat,
designated DLP4 [69], and full-length sequence has been
obtained [15]. Genetic and biochemical studies suggest that
DYNC2H1 associates with a member of the light intermediate
chain family, DYNC2LI1 (Figure 1B, and see discussion of the
light intermediate chain family below) [14,16,70–73] and
possibly also with DYNLL1 (LC8) light chain [72]. In mice
Dync2h1, mRNA is abundant in the olfactory epithelium and
the ependymal layer of the neural tube; antibodies against
DYNC2H1 and DYNC2LI1 strongly stain these tissues and
connecting cilia in the retina as well as primary cilia of non-
neuronal cultured cells [15]. The co-localization of
DYNC2H1, DYNC2LI1, and homologs of the IFT pathway in
mammalian ciliated tissues supports a speciﬁc role for
DYNC2H1 in the generation and maintenance of mammalian
cilia [14,16]. Other antibody studies suggest that DYNC2H1
localizes to the cytoplasm of apical regions of ciliated rat
tracheal epithelial cells, but not in the cilia themselves [74]. In
non-ciliated human COS cells, antibodies against DYNC2H1
show Golgi localization and induce Golgi dispersion,
suggesting a cytoplasmic role for DYNC2H1 [23].
Cytoplasmic Dynein Intermediate Chain Gene
Family (DYNC1I1, DYNC1I2)
Intermediate chains are present in axonemal and/or
cytoplasmic dyneins from yeast to mammals (Figure 2B).
Protein-sequence data demonstrate evolutionary distant
relationships between axonemal and cytoplasmic dynein
intermediate chains; for example, rat DYNC1I1 has 48%
similarity to the Chlamydomonas IC2 axonemal outer arm
dynein intermediate chain encoded by the ODA6 locus
[75,76]. Figure 2B shows the dynein intermediate chain
protein phylogeny. The intermediate chain sequences fall
into two distinct clades, intermediate chains 1 and 2,
comprised of vertebrate species only. An alternative
placement of a Takifugu sequence, as a member of the
intermediate chain 1 clade, is almost as well supported by the
data as the placement shown in Figure 2B (49% bootstrap
support against 51% support). In view of this and with all
non-vertebrate species falling outside these clades, the data
suggest a recent evolutionary origin for the split into
intermediate chain gene 1 and intermediate chain gene 2,
perhaps as part of a ‘‘2R’’ event of genome duplication (see
[77] for review). The absence of an amphibian (Xenopus)
intermediate chain 1 protein may be due to the current
paucity of X. laevis sequences in the GenBank sequence
database (http://www.ncbi.nlm.nih.gov/Genbank).
The cytoplasmic dynein 1 intermediate chains have a
molecular weight of ;74 kDa [5] and associate in the
cytoplasmic dynein complex with a stoichiometry of two
intermediate chains per complex [40,78]. DYNC1I1 and
DYNC1I2 proteins are thought to help assemble the
cytoplasmic dynein complex and to bind various cargoes. The
intermediate chains interact with the dynein activator,
dynactin, via their conserved N-termini [79]. The DYNC1I C-
termini contain a WD repeat domain [76,80,81] that is
conserved between cytoplasmic and axonemal intermediate
chains and is important for intermediate chain–binding to
the heavy chains [76,82]. The dynein light chains, DYNLL1
(LC8) and DYNLT1 (Tctex1), bind near the N-termini of the
intermediate chains [83–85], and the DYNLRB (Roadblock)
light chains bind just upstream of the WD repeat region [40].
The DYNC1I are phosphorylated, and phosphorylation at one
site regulates DYNC1I2 interaction with the p150 subunit of
dynactin [86,87].
The Chlamydomonas IC2 axonemal intermediate chain was
localized to the base of the dynein heavy chain dimer by
immunoelectron microscopy [88]. Steffen and colleagues
identiﬁed a similar location for the cytoplasmic dynein
intermediate chain and found that antibodies to it block
dynein binding to membrane-bound organelles [89,90]. These
data indicate a role for DYNC1I in targeting the dynein
complex to various cargoes, including membranous
organelles and kinetochores [76,79,89]. In Drosophila,
mutations in dynein intermediate chain, Cdic (also referred
to as cDic and Dic), lead to larval lethality, demonstrating that
this intermediate chain provides an essential function. Cdic
mutations dominantly enhance the rough-eye phenotype of
Glued, a dominant mutation in the p150 subunit of dynactin
[91]. Shortwing (sw) is an allele of the dynein intermediate
chain gene but, unlike other Cdic alleles, sw is homozygous
viable and gives rise to a recessive, temperature-sensitive
defect in eye and wing development [91].
We note that in Drosophila, the Cdic gene lies in the 19DE
region of the X chromosome, adjacent to several dynein
intermediate chain-like sequences. These sequences are
derived from a 7-kb duplication/deletion event involving Cdic
and its proximal gene annexin X, which encodes a cell-
surface-adhesion protein [92]. The duplication/deletion of
this 7-kb region resulted in the formation of a de novo coding
sequence, under the control of a testes-speciﬁc promoter,
called sperm-speciﬁc dynein intermediate chain gene (Sdic)
[93]. The de novo region has undergone at least 10-fold
tandem duplication, which has given rise to a multi-gene
family comprising at least four classes of Sdic gene, of which
more than one class is functional [93].
Cytoplasmic dynein 1 intermediate chain 1, DYNC1I1.
Multiple DYNC1I1 isoforms exist in mammals. They are the
products of alternative splicing of the N-terminal region of a
single DYNC1I1 gene and phosphorylation [76,79,86]. In
humans, alternate splicing may arise from cryptic splice-
acceptor sites located within exon 4 of this 17-exon gene [94].
Two DYNC1I1 isoforms were found in rat brain and
DYNC1I1 mRNA, and protein isoform expression is regulated
during rat brain development, and a single DYNC1I1 isoform
is found in testis. DYNC1I1 expression is also cell-speciﬁc:
cultured rat neurons express at least two DYNC1I1
alternative splicing variants and their phosphorylated
isoforms, while cultured glial astrocytes do not express any
DYNC1I1 gene products [95–97]. In the mouse, expression of
Dync1i1 has been shown to be restricted primarily to the
brain, with weak expression in testis [94], further supporting
possible neuronal speciﬁcity for Dync1i1. As with the other
dynein subunits, the isoform diversity of the intermediate
chain is thought to result in speciﬁc populations of dynein
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molecules that have speciﬁc functions; for example, both
DYNC1I1 isoforms are components of cytoplasmic dynein
found in the slow component of axonal transport in the optic
nerves [95]. Multiple isoforms of the Drosophila intermediate
chains are also produced by alternative splicing of the single
gene [92].
Cytoplasmic dynein 1 intermediate chain 2, DYNC1I2.
Vaughan and Vallee used a partial human cDNA sequence
with identity to the already known DYNC1I1 gene as a probe
to isolate a rat Dync1i2 cDNA; predicted human and rat
DYNC1I2 sequences are 94% identical [79], and the existence
of two genes was supported by mapping data that placed
Dync1i1 and Dync1i2 at distinct loci within the mouse genome
[98]. Like Dync1i1, Dync1i2 produces different splice isoforms:
alternative splice sites lie at two positions within the N-
terminal region. The expression of Dync1i2 isoforms is
ubiquitous with the rat DYNC1I2C isoform being expressed
in all tissues and cells examined [79,94,96,97]. During rat
brain development, DYNC1I2C is the only isoform found
before E14 (embryonic day 14) and it is often the only isoform
observed in cultured cells [96,99]. During nerve growth-factor
stimulation of PC12 cell differentiation and neurite
extension, there is a change in relative expression levels of the
DYNC1I2 isoforms [100]. In the rat optic nerve, it has been
shown that the DYNC1I2C isoform is the only intermediate
chain involved in the fast component of anterograde
transport to the axon tip [95,99].
The strong expression of Dync1i2 in the mouse developing
limb bud led to the suggestion that DYNC1I2 may play a role
in limb development and digit patterning and/or in
establishing cell polarity [94]; dynein may not do this directly,
but may mediate these processes by orientating intracellular
components correctly [101].
Cytoplasmic Dynein Light Intermediate Chain Gene
Family (DYNC1LI1, DYNC1LI2, DYNC2LI1)
Figure 2C shows the phylogenetic relationships amongst
the dynein light intermediate chain protein sequences from
various organisms. The light intermediate chains can be
separated into three distinct groups: the two light
intermediate chains that are components of cytoplasmic
dynein 1, DYNC1LI1 and DYNC1LI2, are more closely related
to each other than to the cytoplasmic dynein 2 light
intermediate chain, DYNC2LI1. Hughes and colleagues ﬁrst
proposed the name light intermediate chains for these
subunits [102], although these polypeptides were also referred
to as light chains [103] prior to the discovery of the smaller
light chains [104]. The mammalian cytoplasmic dynein
complex contains four species with molecular masses of 50–
60 kDa that resolve into numerous isoforms on 2D gels
[86,102]. The multiple isoforms observed in 1D and 2D gels
are thought to be the result of post-translational
phosphorylation, although the possibility of alternate splicing
has not been eliminated [86,102,103]. A third gene,
DYNC2LI1, has recently been described which encodes a
protein that appears to exclusively associate with DYNC2H1
in the cytoplasmic dynein 2 complex [14–16,71]. Unlike the
other subunits of cytoplasmic dynein, homologs of the
DYNC1LIs have not yet been identiﬁed in the axonemal
dyneins [105]. The function of the DYNC1LIs has yet to be
determined, although it has been suggested that they may
regulate the interactions of dynein with dynactin, or with
sub-cellular cargoes of dynein-mediated motility. DYNC1LI1
and DYNC1LI2 form only homo-oligomers, and their
mutually exclusive binding to the N-terminal base of the
dynein heavy chain is consistent with a role in cargo binding
[38].
C. elegans appears to have one light intermediate chain (dli-
1) for cytoplasmic dynein (DYNC1H1-based complexes), and
one (xbx-1) for cytoplasmic dynein 2 (DYNC2H1-based
complexes) [73]. dli-1 is required for dynein function during
mitosis, pronuclear migration, centrosome separation, and
centrosome association with the male pronuclear envelope
[106], as well as retrograde axonal transport. Mutations in dli-
1 lead to an accumulation of cargo at axonal terminals [52].
Disruption of xbx-1 results in ciliary defects and causes
behavioral abnormalities that are observed in other cilia
mutants [14]. Binding of dli-1 to ZYG-12 is thought to be the
mechanism for dynein binding to the nuclear envelope [107].
Cytoplasmic dynein 1 light intermediate chain 1,
DYNC1LI1. DYNC1LI1 was cloned from rat [38] and found to
have a P-loop motif, which is one of the major conserved
motifs making up the nucleotide-binding domain found in
numerous proteins, including ATPases and kinases [108].
DYNC1LI1, however, lacks other essential motifs associated
with ATPase activity, which itself has not been assayed. Tynan
showed that pericentrin, a known dynein cargo, binds
DYNC1LI1 and not DYNC1LI2 [38]. DYNC1LI and its
phospho-isoform are exclusively found with dynein in the
slow component of axonal transport in rat optic nerves [95].
In HeLa cells, DYNC1LI1 localizes to the microtubule
organizing centre and mitotic spindle, co-localizing with the
GTPase Rab4a (which interacts with the central domain of
DYNC1LI1 [109]); thus DYNC1LI1 may be implicated in the
regulation of membrane-receptor recycling. Phosphorylation
of the Xenopus DYNC1LI has been implicated in regulation of
dynein binding to membrane-bound organelles [110]. It is
thought that Xenopus melanosomes contain a distinct dynein
light intermediate chain protein, possibly a version of
DYNC1LI1 [111]. In the chicken (Gallus gallus) DYNC1LI1 has
been called DLC-A, as part of the DLC-A group of light
chains [103].
Cytoplasmic dynein 1 light intermediate chain 2,
DYNC1LI2. DYNC1LI2 is paralogous to DYNC1LI1 and is also
thought to be post-translationally modiﬁed by
phosphorylation [86,102,103]. DYNC1LI2 is found in both the
fast and slow components of axonal transport in rat optic
nerves, although its phospho-isoforms are found only in the
slow component of axonal transport. During nerve growth-
factor stimulation of PC12 cell differentiation and neurite
extension, DYNC1LI2 gene expression is up-regulated [112],
and phosphorylation of both DYNC1LI1 and DYNC1LI2 is
increased [100]. Like DYNC1LI1, the chicken (G. gallus)
DYNC1LI2 has also been termed DLC-A, as part of the DLC-A
group of light chains [103].
Cytoplasmic dynein 2 light intermediate chain 1,
DYNC2LI1. DYNC2LI1 is a light intermediate chain that was
identiﬁed in mammals by two groups and was originally
designated D2LIC [14] and LIC3 [15]. DYNC2LI1 is the light
intermediate chain that associates with DYNC2H1 in the
cytoplasmic dynein 2 complex: Grissom and colleagues
observed that DYNC2LI1 co-immunoprecipitated speciﬁcally
with DYNC2H1 and co-localized with DYNC2H1 at the Golgi
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apparatus. Mikami and coworkers [15] found the 350-amino
acid LIC3 polypeptide (AAD34055) had a 24% similarity to
rat DYNC1LI2 but failed to observe Golgi localization.
DYNC2LI1 has been identiﬁed in mouse, C. elegans, Drosophila,
and Chlamydomonas [14,16]. A targeted deletion of Dync2li1 in
mouse affects development, in particular ventral cell fates
and axis establishment in the early embryo [113]. In
Chlamydomonas, DYNC2LI1 (D1bLIC) is essential for
retrograde IFT [71]. As mentioned above, DYNC2LI1 appears
to bind exclusively with DYNC2H1; in agreement with this,
we ﬁnd DYNC2LI1 homologs in species that have DYNC2H1.
The exclusive association of DYNC2H1 and DYNC2LI1 with
one another, and not with any of the other cytoplasmic
dynein subunits, emphasizes the distinct cellular identities
and roles of these separate DYNC1H1 and DYNC2H1 dynein
complexes.
Cytoplasmic Dynein Light Chain Gene Families
There are three known dynein light chain gene families
that are components of cytoplasmic dynein 1: (1) the t-
complex–associated family (DYNLT1, DYNLT3), (2) the
Roadblock family (DYNLRB1, DYNLRB2), and (3) the LC8
family (DYNLL1, DYNLL2). The gene families are named
according to their original discovery, through the effect of
mutations in mouse (t-complex associated, Tctex1) and
Drosophila (Roadblock), or according to the size of the protein
in Chlamydomonas (LC8) as discussed below. We present each
family by molecular weight, starting with the largest light
chain protein gene family, the t-complex–associated family
(;113 amino acids), through to the Roadblock family (;96
amino acids) and the smallest light chain proteins, the LC8
family (;89 amino acids). As described below, some of the
light chains have cellular functions that are independent of
their role in the cytoplasmic dynein 1 complex.
Cytoplasmic Dynein Light Chain Tctex1 Gene Family
(DYNLT1, DYNLT3)
Figure 2D shows the phylogenetic relationships amongst
the dynein light chain Tctex1-family protein sequences from
various organisms. Our phylogeny shows distinct clades for
DYNLT1-like and DYNLT3-like sequences. Tctex2-like
sequences lie closer to the outgroup than they do to the
DYNLT1 and DYNLT3 clades (not shown).
Cytoplasmic dynein light chain Tctex1, DYNLT1. Tctex1 (t-
complex testis-expressed) gene was originally identiﬁed within
the mouse t-complex (a 30- to 40-Mb region of Mmu17) as a
candidate for one of the ‘‘distorter’’ products responsible for
the non-Mendelian transmission of variant t haplotypes [114].
Lader et al. [114] and O’Neill and Artzt [115] found evidence
of four copies of Dynlt1 (Tctex1) in the mouse genome; we
found that the current genomic sequence databases appear to
contain only one such locus that maps to Mmu 17, although a
processed pseudogene has also been described on Mmu6.
Subsequently, DYNLT1 was found to be an integral
component of cytoplasmic dynein [116], and has since also
been identiﬁed within axonemal inner and outer arm dyneins
[117,118]. DYNLT1 binds to the N-terminus of the
intermediate chain DYNC1I [85]. Many studies have
identiﬁed DYNLT1 as a binding partner for various cellular
proteins, and it has been suggested that it may attach speciﬁc
proteins or cellular components to cytoplasmic dynein; for
example, DYNLT1, but not its homolog DYNLT3 (see below),
binds to the C-terminal domain of rhodopsin and is required
for the trafﬁcking of this visual pigment within
photoreceptors [119]. The two DYNLT1 polypeptides in the
cytoplasmic dynein complex dimerize, and their dimer
structure is similar to that of the DYNLL1, LC8, dimer
[116,120–122]. The evidence suggests that the same Dynlt1
gene product is a component of both axonemal and
cytoplasmic dyneins in mouse [117]. The binding site on
DYNC1I for DYNLT1 has been mapped to a 19-amino acid
region at the N-terminus [85].
The Schizosaccharomyces pombe DYNLT-like gene
SPAC1805.08 (also referred to as Dlc1) is involved in
movement of nuclear material during meiotic prophase and
is expressed in astral microtubules and microtubule-
anchoring sites on the cell cortex. The Dlc1 localization
pattern is similar to that of cytoplasmic dynein heavy chain
Dhc1 [123]. Dlc1 null mutants are viable but have irregular
nuclear movement during meiosis and defects in sporulation,
recombination, and karyogamy [123]. Genetic analyses in
Drosophila, which appears to have only one member of the
DYNLT family, suggest that DYNLT1 is not essential for
cytoplasmic dynein function, as the null mutation is not
lethal. However, the mutants do have sperm-motility defects,
suggesting they do have an essential role in axonemal dynein
[124,125]. In Chlamydomonas, Tctex1 is an axonemal inner arm
dynein component [117], and recently a variant form has
been identiﬁed in axonemal outer arm dynein (DiBella et al.,
in press).
Cytoplasmic dynein light chain, DYNLT3. Closely related
to DYNLT1 is DYNLT3, also known as rp3 because it was
initially a candidate for causing X-linked retinitis pigmentosa
type 3 [126]. However, the actual gene that is defective in this
disease was later identiﬁed as a guanine nucleotide exchange
factor that is unrelated to DYNLT3 [127]. Subsequently, King
and colleagues found that DYNLT3 is a cytoplasmic dynein
light chain that is differentially expressed in a cell- and tissue-
speciﬁc manner [78,116]. Interestingly, while many proteins
have been identiﬁed as binding partners for DYNLT1, none
have been identiﬁed as binding exclusively to DYNLT3,
though recently the Herpes simplex virus capsid protein VP26
has been shown to bind both DYNLT1 and DYNLT3 [128].
There is no evidence that DYNLT3 is a component of
axonemal dyneins.
Axonemal dynein light chain, Tctex2. To avoid confusion
with Tctex2, an axonemal dynein subunit, the DYNLT2
designation is not used: a third human t-complex testis-
expressed gene, originally characterized by Rappold and
colleagues [129,130], was given the name Tctex2, and is also
known as LC2, TCTE3, and Tcd3. Patel-King and colleagues
demonstrated that it has 35% identity to the 19,000-Mr
(relative mobility) axonemal outer arm dynein light chain
(LC2) of Chlamydomonas [131], and that it is distantly related to
cytoplasmic light chains DYNLT1 and DYNLT3 [116,120].
LC2 is essential for outer arm dynein assembly [132]. There is
evidence that Tctex2 may interact substoichiometrically with
cytoplasmic dynein, but there has not yet been a deﬁnitive
demonstration that it is a cytoplasmic dynein subunit.
In mice, expression of Tctex2 is testis-speciﬁc, particularly
in later spermatogenic stages, and isoforms are thought to be
generated by alternative splicing [130]. As yet, isoforms of the
human homolog have not been identiﬁed, and its expression
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is restricted to tissues containing cilia and ﬂagella [133].
Mutations in Tctex2 have been implicated in the autosomal
recessive disorder primary ciliary dyskinesia, which results in
the impairment of ciliary and ﬂagellar function, although
these mutations are thought not to be the primary cause of
the disorder [133].
Mouse Tctex2 lies within the Mmu17 t-complex in a central
region containing the distorter/sterility locus Tcd3 [134].
Human Tctex2 maps to the long arm of Chromosome 6 [129]
and, interestingly, is a neighbor of the two genes, TCP1 and
TCP10, which are also homologs of mouse t-complex loci
found adjacent to mouse Tctex2. This conservation of gene
order suggests that the region of Chromosome 6q containing
these genes is syntenic to the homologous central region of
mouse Chromosome 17. In contrast, DYNLT1 and DYNLT3
are located on human Chromosome 6p and show synteny to
the distal portion of the mouse t-complex, suggesting that the
middle and distal portions of the mouse t-complex are
syntenic to the long and short arms of human Chromosome 6,
respectively [129].
Cytoplasmic Dynein Light Chain Roadblock Gene
Family (DYNLRB1, DYNLRB2)
The ﬁrst Roadblock gene was identiﬁed in Drosophila
through mutational analyses, and from biochemical and
sequence comparisons with the Chlamydomonas outer arm
dynein LC7a light chain [135,136]. Drosophila has at least six
Roadblock homologs, including bithoraxoid, which has been
implicated in thoracic and abdominal parasegment
development. These proteins belong to an ancient family that
has been implicated in NTPase regulation in bacteria [137].
Mutations in the Roadblock genes result in the accumulation
of axonal cargoes, mitotic defects, female sterility, and either
larval or pupal lethality [135]. Roadblock mutations also
affect neuroblast proliferation and result in reduced
dendritic complexity, as well as in defects in axonal transport
[138]. Mutational analysis in Chlamydomonas suggests that
DYNLRB (LC7a) is involved in axonemal outer arm dynein
assembly, and a related protein (LC7b) is associated with
dynein regulatory elements [136,139].
Figure 2E shows the phylogenetic relationships amongst
the dynein light chain Roadblock-family protein sequences
from various organisms. The Roadblock sequences are
remarkably well conserved between different organisms, with
96% of pair-wise sequence comparisons amongst all
sequences shown in Figure 2E demonstrating an identity
greater than 50% (data not shown). The high conservation of
Roadblock-family sequences presumably arises from
functional constraints on the proteins. We note that genes in
mammals and in other species incorporate conserved and
complete Roadblock sequences (known as Roadblock
domains) within their coding regions [135,137]. However,
these genes are not thought to be cytoplasmic dyneins; for
example, MAPBPIP in human and mouse appears to function
mainly in the endosome/lysosome pathway [140]. Both
DYNLRB polypeptides are found in mammalian cytoplasmic
dynein, but it is not yet known if just one, or both, are utilized
in mammalian axonemal dyneins.
Cytoplasmic dynein light chain Roadblock1, DYNLRB1.
Database searches [135,141] (Figure 2E) revealed there are
two Roadblock-related proteins in mammals, DYNLRB1 and
DYNLRB2 (also termed DYNLC2A and DYNLC2B) [142].
Biochemical studies suggest that in mammals both
Roadblocks exist as homo- and heterodimers that associate
with cytoplasmic dynein [143] through speciﬁc binding sites
on the intermediate chains, distinct from those for the
DYNLL (LC8) and DYNLT (Tctex1) light chains [40].
Expression studies in humans have identiﬁed tissue-speciﬁc
differences in the expression of the two human Roadblock-
like genes, with strong expression of DYNLRB1 in heart, liver,
and brain, and up-regulation in hepatocellular carcinoma
tissues [142]. In a role that may be independent of its
association with cytoplasmic dynein, TGFb phosphorylation
of human DYNLRB1 (termed mLC7–1/km23 by Tang and
colleagues [144]) results in the human DYNLRB1 binding to
the TGFb receptor that mediates TGFb responses including
JNK activation, c-JUN phosphorylation, and growth
inhibition.
Cytoplasmic dynein light chain Roadblock 2, DYNLRB2.
DYNLRB2 was identiﬁed by EST database searches for
sequences homologous to Chlamydomonas LC7a [135,141];
human DYNLRB2 was cloned in 2001 [142] and was found to
be differentially expressed in various tissues, including
hepatocellular carcinomas.
Cytoplasmic Dynein Light Chain LC8 Gene Family
(DYNLL1, DYNLL2)
Cytoplasmic dynein light chain LC8 1, DYNLL1. DYNLL
(the light chain that has been known as LC8, as well as LC8a
and PIN) is a component of many enzyme systems, and it has a
long and somewhat confusing history. This protein was
originally identiﬁed, using biochemical methods, as a light
chain of the Chlamydomonas axonemal outer arm dynein
[145,146]. The term LC8 derives from the observation that this
component migrates at ;8 kDa in SDS-PAGE gels, and it is
also the smallest of the eight light chains then known within
this Chlamydomonas axonemal dynein. It was ﬁrst cloned from
Chlamydomonas, and closely related sequences were identiﬁed
in mouse and nematode along with more distantly related
proteins in higher plants [147,148]. Using biochemical and
immunochemical methods, DYNLL was also identiﬁed as an
integral component of brain cytoplasmic dynein [104]. Only
recently, it has been realized that mammals have two closely
related DYNLL genes, and that the protein products of both
genes are components of cytoplasmic dynein [148,149]. Thus,
most of the studies on the cellular roles of DYNLL do not
distinguish between the two DYNLL polypeptides.
Another factor complicating efforts to elucidate the role of
the DYNLL polypeptides in dynein function was the
realization that large amounts of DYNLL1 in brain, and
presumably cells in general, are not associated with the
dynein complex [104]. In fact, the DYNLL polypeptides have
other important functions unrelated to their role in
axonemal and cytoplasmic dyneins. DYNLL1 is a subunit of
the ﬂagellar radial spokes which are involved in control of
axonemal dynein motor function [150]. DYNLL1 is also a
substrate of a p21-activating kinase, and its interaction with
the kinase may be important for cell survival [151]. A DYNLL
is an integral component of the actin-based motor myosin V
[152]. Immunostaining shows that a DYNLL is concentrated
in dendritic spines and growth cones, and it is proposed that
this is due to its association with the actin-based motor
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myosin V [149]. DYNLL1 was identiﬁed within neuronal
nitric oxide synthase (nNOS) [14] and named ‘‘PIN’’ for
‘‘protein inhibitor of nNOS’’ [153]. However, it is unclear
whether it is actually an inhibitor of nNOS or is merely a
component of the nNOS complex, as DYNLL1 appears to be
required for the stability of various multimeric enzyme
complexes. DYNLL1 has been found to interact with a wide
variety of other cytoplasmic components, including the pro-
apoptotic factor Bim [154], Drosophila swallow [155,156], and
rabies virus P protein [157], and it may act to attach them to
the dynein and/or myosin-V molecular motors. In addition,
there are many other DYNLL-interacting proteins not
mentioned here that have been identiﬁed using yeast two-
hybrid screens and other methods.
There are two copies of DYNLL in the cytoplasmic dynein
complex, and the crystal and NMR structures of the DYNLL
dimer with bound peptide are known [104,158–160]. Both
monomers contribute to the formation of two symmetrical
grooves in the dimer that are the binding sites for two DYNC1I
polypeptides reviewed in [161]. Adding DYNLL to an N-
terminal polypeptide of DYNC1I in vitro increases the
structural order of DYNC1I, suggesting that DYNLL is
important for the assembly of a functional dynein complex [84].
Figure 2F shows the phylogenetic relationships amongst the
dynein light chain LC8-family protein sequences from
various organisms. Our phylogeny shows that the mammalian
LC8 light chain family falls into two distinct clades containing
DYNLL1- and DYNLL2-like genes. DYNLL is highly
conserved from alga and humans, and homologs are required
for sensory axon projection and other developmental events
in Drosophila [162,163], nuclear migration in Aspergillus [164],
and retrograde IFT in Chlamydomonas [72]. The phenotype of
partial loss-of-function mutants in Drosophila revealed a wide
array of pleiomorphic developmental defects; the total loss-
of-function mutation was embryonic lethal [162]. The
Drosophila dynein light chain 1 (Cdlc1, also known as ddlc1
and ‘‘cut-up’’ [ctp]) is ubiquitously expressed during
development and in adult tissue, and is required for proper
embryogenesis and cellular differentiation. Mutations in this
gene result in female sterility, which may be due to the
severely disordered cytoskeletons of ovarian and embryonic
cells [162]. A high degree of sequence similarity (92%) exists
between Drosophila Cdlc1 and the 8-kDa ﬂagellar outer arm
dynein light chain from Chlamydomonas, and with human and
C. elegans light chain 1 (91%), suggesting this gene has been
under strong selective pressure [162]. S. pombe has a single
known DYNLL homolog, SPAC926.07c (also referred to as
Dlc2); it is transcribed during the vegetative phase, induced at
low level in the sexual phase, and is enriched at the nuclear
periphery [123]. A Dlc2 null mutant has been described with
marginally reduced recombination in meiosis, but no other
reported phenotype [123].
During the course of homology searches for this paper, we
noted that DYNLL1 has related sequences in several locations
in the human genome (data not shown); none of these appear
to be associated with expressed sequences and thus may be
pseudogenes. There was also a discrepancy in the likely
mapping position of DYNLL1, and therefore we carried out a
sequence analysis of DYNLL1-related genomic loci and show
that the cognate human locus lies on Hsa12q24.31 (data not
shown), which agrees with the mouse mapping result of Dynll1
on Mmu5.
Cytoplasmic dynein light chain LC8 2, DYNLL2. DYNLL2,
also known as DYNLL2 and LC8b, is the secondmember of this
light chain family. It was identiﬁed by micro-sequencing of
polypeptides from puriﬁed brain cytoplasmic dynein [148] and
a yeast two-hybrid screen [149]. Mammalian DYNLL1 and
DYNLL2 have 93% identity, differing by only six amino acids
out of 89. Indicative of the extraordinary conservation of these
proteins, the amino acid sequences of both DYNLL1 and
DYNLL2 from human, mouse, rat, pig, and cow are identical
[148]. Human DYNLL2 was identiﬁed in a yeast two-hybrid
screen using the guanylate kinase–associated protein (GKAP)
as bait and may mediate the interaction between GKAP and
actin- and microtubule-based motors, allowing GKAP and its
associated proteins to be translocated as a cargo, although
DYNLL1 also binds to GKAP [149]. DYNLL2 binds the pro-
apoptotic factor Bmf, which binds Bcl2, neutralizing its
antiapoptotic activity, a role comparable to that reported for
the binding of Bim to DYNLL1 [165]. However, it has also been
observed that Bim and Bmf have identical binding afﬁnities for
both DYNLL1 and DYNLL2 [166].
It has further been proposed that DYNLL1 binds
speciﬁcally to the dynein intermediate chain DYNC1I, while
DYNLL2 binds to the myosin-V heavy chain. However,
DYNLL2 co-puriﬁes with cytoplasmic dynein from various rat
tissues [148], and DYNLL1- and DYNLL2-GST are equally
effective in binding myosin V [149]. Furthermore, DYNLL1
and DYNLL2 bind with equal afﬁnity to DYNC1I in pair-wise
yeast two-hybrid studies (K. W. Lo and K. K. Pﬁster,
unpublished data). It is not yet known if one, or both, of the
DYNLL polypeptides are associated with axonemal dyneins;
however, DYNLL1 is enriched in testes and lung—tissues that
have large numbers of cilia or ﬂagella [148].
Human and Mouse Cytoplasmic Dyneins:
Nomenclature, Map Positions, and Sequences
To create Table 1, we cataloged, by literature searches, all
known gene and protein names for the cytoplasmic dyneins
in mouse and human. In addition, aliases were recorded from
the single-query interface LocusLink (http://www.ncbi.nlm.
nih.gov/LocusLink) and the Mouse Genome Informatics
(MGI) website (http://www.informatics.jax.org). We also
included aliases previously approved by the HUGO Gene
Nomenclature Committee (http://www.gene.ucl.ac.uk/
nomenclature) as well as aliases referenced in sequence
submissions to the GenBank (http://www.ncbi.nlm.nih.gov/
Genbank) and Entrez (http://www.ncbi.nlm.nih.gov/entrez)
sequence databases [167].
Human and mouse orthologs in Table 1 are taken from the
literature and databases. Human and mouse chromosomal
locations were obtained from the literature and from the
MGI and LocusLink databases. The OMIM numbers given for
gene and disease loci in humans refers to the unique
accession numbers in the On-line Mendelian Inheritance in
Man database (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼OMIM). Nucleotide and protein sequences (preﬁx
NM_ and NP_, respectively) are National Center for
Biotechnology Information (NCBI) Reference Sequence
(RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq) and Swiss-Prot
accession numbers (http://www.ebi.ac.uk/swissprot),
respectively [167]. The NCBI RefSeq project provides a non-
redundant and comprehensive collection of nucleotide and
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protein sequences drawn from the primary-sequence
database GenBank. RefSeq collates and summarizes primary-
sequence data to give a minimal tiling path for individual
transcripts, using available cDNA and genomic sequence
whilst removing mutations, sequencing errors, and cloning
artifacts. Sequences are validated in silico by NCBI’s Genome
Annotation project to conﬁrm that any genomic sequence
incorporated into a RefSeq cDNA matches primary cDNA
sequences in GenBank, and that the coding region really can
be translated into the corresponding protein sequence.
Accession numbers beginning with the preﬁx XM_ (mRNA)
and XP_ (protein) are RefSeq sequences of transcripts and
proteins that are annotated on NCBI genomic contigs; these
may have incomplete cDNA-tiling-sequence data or contig
sequences [168]. For dyneins with known isoforms, isoform-
sequence accession numbers available within nucleotide and
protein databases are given.
Included in the heavy chains that we found were ‘‘Cell
Division Cycle 23, yeast homolog’’ (CDC23) and ‘‘Cell Division
Cycle 22, yeast homolog’’ (CDC22), which are GenBank aliases
for human and mouse dynein heavy chain 1, respectively. We
found no evidence in the literature to support the ‘‘CDC’’
designation of these genes and their products in terms of
either ‘‘Cell Division Cycle’’ or ‘‘Cytoplasmic Dynein Chain’’.
We compared mouse and human heavy chain 1 cDNA and
protein sequences with mouse, human, and yeast CDC23 and
CDC22 sequences and found no similarity to support this
designation (data not shown). We concluded that the
synonym CDC had most likely been attributed in error, and
we contacted NCBI who, in agreement with our ﬁndings,
removed the CDC designation from the sequences involved.
Human/Mouse Homology Searches
Homology searches of human cytoplasmic dynein subunit
genes were conducted using position-speciﬁc iterative BLAST
(PSI-BLAST) [169] at NCBI (http://www.ncbi.nlm.nih.gov/
BLAST; Table 2). The PSI-BLAST program identiﬁes families
of related proteins using an iterative BLAST procedure [170].
In an initial search, a position-speciﬁc scoring matrix is
constructed from amultiple sequence alignment of the highest
scoring hits. Subsequent iterations using the position-speciﬁc
scoring matrix are performed in a new BLAST query to reﬁne
the proﬁle and ﬁnd additional related sequences. We used
nucleotide and protein sequences from each known human
dynein gene to query the human and mouse non-redundant
sequence databases at GenBank, using default parameters and
the BLOSUM-62 substitution matrix, which has been shown to
be the most effective substitution matrix to identify new
members of a protein family [171].Where dynein isoformswere
present, the longest sequence was used to search the databases.
Phylogenetic Analysis
To establish gene family groupings, we investigated the
phylogenetic relationships between dynein protein homologs
in various organisms. Homologous sequences were identiﬁed
by searching the GenBank non-redundant protein database,
with the human protein using PSI-BLAST with default
parameters and the BLOSUM-62 substitution matrix.
Searches of pufferﬁsh sequence Takifugu rubripes (commonly
known as Fugu rubripes), for which little transcribed sequence
exists although a usable genome assembly is present, were
performed using the BLAST (TBLASTN) feature at the
Ensembl Fugu Genome Browser (version 2.0; http://
www.ensembl.org/Fugu_rubripes), searching with human
protein sequence against a translated nucleotide database.
Protein sequences were aligned for comparison across their
full lengths using the multiple sequence alignment program
CLUSTALW [172] (http://www.ebi.ac.uk/clustalw) and
applying the GONNET250 matrix as default. The
GONNET250 is a widely used matrix for performing protein-
sequence alignments, allowing 250 accepted point mutations
per 100 amino acids, using scoring tables based on the
PAM250 matrix [173].
Two different phylogenetic methods were used to analyse
the dynein gene family alignments. Maximum-likelihood trees
were inferred under the Jones, Taylor, and Thornton (JTT)
empirical model of amino-acid substitution using PHYML
version 2.4.3 [174], as was non-parametric bootstrapping
using 100 resampled alignments for each gene family.
Bayesian analyses were performed using MrBayes version
3.0B4 [175], using the default Bayesian priors on tree
topologies and branch lengths. Two different sets of analyses
were performed for each gene family, the ﬁrst allowing the
Markov-chain Monte-Carlo algorithm to move between the
11 different amino-acid substitution models available in
MrBayes, and another specifying the JTT model. The ﬁrst
analysis allows the chain to take into account uncertainty in
the substitution process. For all analyses performed here, the
posterior probability of the JTT model was at least 99%,
conﬁrming that this model best describes the evolution of the
dynein sequences—so only results from the ﬁxed-JTT model
analyses are shown here.
For each analysis, three chains of 1,000,000 generations each
were run, sampling parameters every 100 generations and
discarding the ﬁrst 100,000 generations as a burn-in period.
Running these multiple independent chains allowed visual
conﬁrmation that the chains had reached a stationary state by
ensuring that all three chains were moving around a region of
similar likelihood. For one of the gene families (cytoplasmic
dynein heavy chain), the three chains had reached different
likelihood values after 1,000,000 generations, suggesting failure
to converge. Running another three independent chains
resulted in ﬁve out of six chains agreeing on the likelihood
values, suggesting that only one chain had not converged
properly. In all cases, the phylogeny presented is the majority-
rule consensus of the posterior sample of tree topologies from
all three Markov chains, drawn using TreeView [176] with
posterior clade probabilities and maximum-likelihood
bootstrap values shown for each clade on these trees.
Searching for Function and Mutant Phenotypes
As well as literature searches, information on protein
function was taken from the Gene Ontology database (http://
www.geneontology.org), which provides data on function and
processes associated with a search protein. Mutant-
phenotype data were obtained from the literature and the
following sources: Online Mendelian Inheritance in Man at
NCBI for human (http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db¼OMIM); MGI for mouse (http://www.
informatics.jax.org); FlyBase for Drosophila (http://www.ﬂybase.
org); and WormBase for C. elegans (http://www.wormbase.org).
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Conclusions
In this paper, we have provided an overview of the two
cytoplasmic dynein complexes, cytoplasmic dynein 1 and
cytoplasmic dynein 2, from a genetic perspective. We have
highlighted the unique subunit compositions and cellular
functions of the two cytoplasmic dyneins, and we have
emphasized the unique role of cytoplasmic dynein 2 in IFT.
We have described the different mammalian dynein gene
families, and have shown the phylogenetic and functional
relationships between members of individual families. We
carried out initial database searches and clariﬁed and
corrected anomalous data. We have also discussed known
functions and mutations of these proteins, and we have
highlighted both their fundamental importance to the cell
and the fact that much research remains to be carried out to
deﬁne the roles of individual proteins.
Supporting Information
Table S1. Species Names, NCBI/GenBank Protein-Sequence
Accession Numbers, and NCBI/GenBank Gene/Protein Names for
Figures 2A–F
Found at DOI: 10.1371/journal.pgen.0020001.st001 (53 KB DOC).
Accession Numbers
The Entrez Gene database (http://www.ncbi.nlm.nih.gov/entrez)
accession numbers for the proteins discussed in this paper are Cdic
(also referred to as cDic and Dic) (44160); che-3 (DYNC2H1 homolog)
(172593); DYNC1I1 (1780); DYNC1I2 (1781); DYNC1LI1 (51143);
DYNC1LI2, (1783); DYNC2H1, (79659); DYNC2LI1 (51626); DYNLL1
(LC8) (8655); DYNLL2 (also known as DYNLL2 and LC8b) (140735);
DYNLRB1 (also termed DYNLC2A) (83658); DYNLRB2 (also termed
DYNLC2B) (83657); DYNLT1 (Tctex1) (6993); MAPBPIP (28956);
SPAC1805.08 (also referred to as Dlc1) (3361491).
The Entrez Gene database (http://www.ncbi.nlm.nih.gov/entrez)
accession numbers for the genes discussed in this paper are Dhc64C
(38580); dli-1 (178260); dyn1 (853928); Dync1h1 (13424); DYNC1H1
(1778) ; Dync1i1 (13426); Dync1i2 (13427); Dync2li1 (213575); Dynlt1
(Tctex1) in the mouse genome (21648); DYNLT3 (6990); human Tctex2
(also known as LC2, TCTE3, and Tcd3) (6991); mouse Tctex2 (21647);
xbx-1 (184080).
The Entrez Protein database (http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db¼protein&cmd¼search&term¼) accession numbers for
the proteins discussed in this paper are C. elegans LC8 sequence
(49822); C. elegans light chain 1 (498422); Cdlc1 (525075);
Chlamydomonas 19,000-Mr axonemal outer arm dynein light chain
(LC2) (AAB58383); rat DYNC1I1 (062107); rat DYNC1LI2 (112288).
The OMIM (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼OMIM) accession numbers for the proteins discussed in this
paper are autosomal recessive disorder primary ciliary dyskinesia
(242650); Bim (603827); Bmf (606266); X-linked retinitis pigmentosa
type 3 (300389).
The Ensembl (http://www.ensembl.org/Fugu_rubripes/textview)
accession number for the Takifugu LC8 sequence is
SINFRUP0000015498.
The SwissProt (http://ca.expasy.org/sprot/) accession numbers for
the Chlamydomonas 8-kDa ﬂagellar outer arm dynein light chain and
the Chlamydomonas LC2 light chain used as the outgroup in Figure 2
are Q39580 and T08216, respectively. “
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